TrialAntimicrobial agents and chemotherapy2001

Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing.

B M Sadler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.